SPEEDBioSystems TURBO293 Transfection Reagents
Closed Solicitation Posted
- Solicitation number
- NOI-NIAID-25-2254745
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health intends to negotiate a non-competitive procurement directly with SPEED BioSystems, LLC for TURBO293 Transfection Reagents. The solicitation is a Notice of Intent to award a purchase order for 46 units of 20ML TURBO293 Transfection Reagent (Catalog # PXX1002). The government recognizes SPEED BioSystems as the sole owner, developer, and seller of these specific reagents, which are currently being utilized by NIAID under existing continuity protocols and compatibility requirements. While the notice allows for interested vendors to submit capabilities statements, the government maintains sole discretion in determining whether to conduct this procurement competitively. Interested parties may submit their capabilities and past performance documentation to Jessica Emerson, the Contracting Specialist, prior to the closing date of January 22, 2025.
The contract opportunity is not set aside for any specific business category, though SPEED BioSystems is classified as a small business. The procurement falls under NAICS code 325414 for Biological Product Manufacturing, with a business size standard of 1,250 employees. The goods will be shipped to the Vaccine Research Center, Building 40, Room 4609, located at 40 Convent Drive in Bethesda, Maryland 20892, with delivery terms specified as FOB Destination. The government reserves the right to use any submitted information for purposes deemed necessary and legally appropriate, and is not obligated to acknowledge receipt of or provide feedback on responses. While no specific award value is mentioned, the procurement appears focused on a specific quantity of specialized scientific reagents critical to ongoing research protocols.
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with SPEED BioSystems, LLC. 900 Clopper Road, Suite 130, Gaithersburg, MD 20878 to procure: TURBO293 TRANSFECTION REAGENT (20ML) QTY 46 CAT # - PXX1002 Shipping location: FOB DESTINATION Vaccine Research Center BLDG 40 RM 4609 40 Convent Drive Bethesda, MD 20892 The North American Industry Classification (NAICS) code for this acquisition is 325414 Biological Product (except Diagnostic) Manufacturing, with a business size standard of 1250 employees. SPEED BioSystems, LLC. is a small business. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government intends to award a purchase order for this requirement after the end of this notice. While this combined synopsis/solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that SPEED BioSystems, LLC is the sole owner, developer, and seller of the required reagents currently being utilized by NIAID per continuity protocols and compatibility requirement. However, vendors that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact prior to the closing date and time of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement on NOI-NIAID-25-2254745 This notice does not obligate the Government to award a purchase order or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. For additional information or to submit responses, please contact Jessica Emerson, Contracting Specialist at jessica.emerson@nih.gov
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - B2B Award entitled - Developing Red Cell-Sp | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity